Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114409571B details a metal-free, one-pot synthesis of nitriles from aldehydes using imidazole hydrochloride, offering high yields and operational simplicity for industrial supply chains.
Novel synthesis of fleroxacin aldehyde thiosemicarbazone derivatives offers enhanced antitumor activity and scalable production for reliable pharmaceutical intermediate supply chains.
Patent CN112321539A enables green epoxidation with high yield. Offers supply chain reliability and cost reduction for fine chemical intermediates manufacturing globally.
Advanced catalytic hydrogenation of citral to citronellol via metal ion modulation. Enhances selectivity and catalyst life for cost-effective fragrance manufacturing.
Patent CN101874016A details a scalable mesylate-based route for CNS drug intermediates, offering superior purity and cost-effective manufacturing solutions.
Optimized preparation of Bilastine via stable carboxylic acid intermediates. Avoids ether cleavage impurities. Ideal for reliable API supplier partnerships.
Novel three-step synthesis route for 7-tert-butyl triazolopyrazine intermediate ensures high purity and scalable production for global pharmaceutical supply chains.
Patent CN104030996B details a novel Valsartan refining method ensuring high optical purity and yield. Discover cost-effective supply chain solutions for chiral API production.
Advanced aqueous synthesis of 2-amino malonamide via patent CN113831255B. High-purity Favipiravir intermediate with optimized cost and scalable production capabilities.
Patent CN104193624A reveals safer supported nickel catalyst for diaminotoluene. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101323579A reveals high-purity m-phenylenediamine synthesis via Pd-Ru catalyst. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Discover the safer Caspofungin synthesis method in patent CN102219833A. Replaces toxic thiophenol with benign agents for cost-effective, scalable pharmaceutical manufacturing.
Novel silylation-based preparation method for Plazomicin antibiotic intermediate improves yield and scalability for pharmaceutical manufacturing supply chains.
Patent CN107629006B reveals a green one-step synthesis of clotrimazole using HFIP. Achieve 92% yield with simplified purification and reduced environmental impact.
Patent CN110643556A details a novel recombinant E. coli strain for efficient prenol synthesis, offering superior regioselectivity and reduced manufacturing costs for global supply chains.
Patent CN102050742B details amorphous nickel catalyst for high selectivity. Enhances supply chain stability and reduces purification costs for global buyers.
Novel PTC route for metoprolol base offers superior yield and purity over traditional methods, ensuring reliable supply chain stability.
Patent CN108192932B details a mild enzymatic route for chiral alcohols, offering high ee values and scalable production for pharmaceutical intermediates.
Advanced industrial synthesis of spiro[benzo[e][1,3]oxazine-2,4'-piperidine]-4(3H)-one via base catalysis. Offers cost reduction and scalable pharmaceutical intermediate production.
Patent CN102942543B details a high-yield synthesis route for benzofuranone derivatives offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.